Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | AMGN | BMY | VRTX | GILD |
| Company | Emergent Biosolutions | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 8.95 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 9.25 | 289.13 | 58.22 | 455.43 | 89.07 |
| Low | 8.83 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 9.22 | 289.40 | 58.00 | 448.30 | 89.04 |
| Change | +0.34 | +1.53 | +0.12 | -2.93 | +0.41 |
| % Change | +3.83% | +0.53% | +0.21% | -0.65% | +0.46% |
| Volume | 397,722 | 603,484 | 1,613,564 | 267,907 | 802,891 |
| 20-Day Average Volume | 1,598,097 | 2,769,439 | 12,097,357 | 1,281,661 | 7,360,405 |
| Previous Close | 8.88 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.50 | 307.25 | 55.90 | 479.10 | 90.84 |
| 20-Day Raw Stochastic | 27.59% | 20.95% | 65.21% | 3.33% | 21.06% |
| 20-Day Relative Strength | 49.70% | 34.30% | 59.84% | 40.14% | 51.39% |
| Weighted Alpha | +58.39 | +0.33 | +24.94 | +17.05 | +24.17 |
| Today's Opinion | 40% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 72% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.89% since 11/14/24 | -3.15% since 11/14/24 | -1.10% since 11/14/24 | -7.51% since 11/14/24 | -3.62% since 11/14/24 |
| Low | 7.71 on 11/15/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 9.25 on 11/21/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -10.66% since 10/21/24 | -9.52% since 10/21/24 | +11.00% since 10/21/24 | -6.37% since 10/21/24 | +2.89% since 10/21/24 |
| Low | 7.71 on 11/15/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 12.73 on 11/07/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -13.30% since 08/21/24 | -12.93% since 08/21/24 | +19.44% since 08/21/24 | -7.92% since 08/21/24 | +18.17% since 08/21/24 |
| Low | 5.69 on 09/25/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 12.73 on 11/07/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +75.58% since 05/21/24 | -8.97% since 05/21/24 | +36.87% since 05/21/24 | +1.27% since 05/21/24 | +31.94% since 05/21/24 |
| Low | 4.51 on 05/29/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 15.10 on 07/30/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 481,154 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 54,184 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 1,049,300,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -760,500,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 293,800,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 114,800,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.57 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.37 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |